Literature DB >> 22641163

Prostate cancer: PSA testing in older men--are we following the guidelines?

William Dale.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22641163     DOI: 10.1038/nrurol.2012.115

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  6 in total

1.  Cause of death in older men after the diagnosis of prostate cancer.

Authors:  Melanie Ketchandji; Yong-Fang Kuo; Vahakn B Shahinian; James S Goodwin
Journal:  J Am Geriatr Soc       Date:  2008-11-18       Impact factor: 5.562

2.  Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2008-08-05       Impact factor: 25.391

3.  Prostate-specific antigen testing in older men in the USA: data from the behavioral risk factor surveillance system.

Authors:  Emil Scosyrev; Guan Wu; Dragan Golijanin; Edward Messing
Journal:  BJU Int       Date:  2012-03-27       Impact factor: 5.588

Review 4.  The role of anxiety in prostate carcinoma: a structured review of the literature.

Authors:  William Dale; Pinar Bilir; Misop Han; David Meltzer
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

5.  Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.

Authors:  Julia H Hayes; Daniel A Ollendorf; Steven D Pearson; Michael J Barry; Philip W Kantoff; Susan T Stewart; Vibha Bhatnagar; Christopher J Sweeney; James E Stahl; Pamela M McMahon
Journal:  JAMA       Date:  2010-12-01       Impact factor: 56.272

6.  Cancer screening in elderly patients: a framework for individualized decision making.

Authors:  L C Walter; K E Covinsky
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

  6 in total
  3 in total

1.  Trial watch: Naked and vectored DNA-based anticancer vaccines.

Authors:  Norma Bloy; Aitziber Buqué; Fernando Aranda; Francesca Castoldi; Alexander Eggermont; Isabelle Cremer; Catherine Sautès-Fridman; Jitka Fucikova; Jérôme Galon; Radek Spisek; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2015-04-02       Impact factor: 8.110

2.  Trial watch: DNA vaccines for cancer therapy.

Authors:  Laura Senovilla; Erika Vacchelli; Pauline Garcia; Alexander Eggermont; Wolf Hervé Fridman; Jérôme Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-04-01       Impact factor: 8.110

3.  Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications.

Authors:  Mark V Mishra; Michele Bennett; Armon Vincent; Olivia T Lee; Costas D Lallas; Edouard J Trabulsi; Leonard G Gomella; Adam P Dicker; Timothy N Showalter
Journal:  PLoS One       Date:  2013-09-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.